Pathophysiology of Cardiac Performance
Exercise and Cardiovascular Response
Cardiovascular Drugs: Classification based on Therapeutic Indications
Antianginal Drugs: Nitrates and β-Blockers
Exercise and Cardiac Output
Heart Failure Drugs: β-Blockers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 9, 2026

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
Published on: February 9, 2016
André La Gerche1, Maria J Brosnan2
1From Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (A.L.G., M.J.B.); St Vincent's Hospital, Fitzroy, Victoria, Australia (A.L.G., M.J.B.); and Department of Cardiovascular Medicine, University of Leuven, Belgium (A.L.G.). andre.agerche@bakeridi.edu.au.
Performance-enhancing drugs (PEDs) pose health risks beyond direct cardiovascular effects, including exercise-induced arrhythmias. Athletes may face dangers from novel, unmonitored agents before regulatory awareness.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: